Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the international Breast Cancer Study Group (IBCSG) trial VI
- 1 April 1998
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (5), 632-640
- https://doi.org/10.1016/s0959-8049(97)10036-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.Journal of Clinical Oncology, 1996
- Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-upNew England Journal of Medicine, 1995
- Chemotherapy induced amenorrhoea in a randomised trial of adjuvant chemotherapy duration in breast cancerEuropean Journal Of Cancer, 1993
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancerBritish Journal of Cancer, 1991
- The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patientsAnnals of Oncology, 1990
- Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancerBreast Cancer Research and Treatment, 1985
- 1-Phenylalanine mustard (L-PAM) in the management of premenopausal patients with primary breast cancer.Lack of association of disease-free survival with depression of ovarian functionCancer, 1979
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958